US2020330537A1PendingUtilityA1

Tobacco products with cannabinoid additives and methods for reducing the harm associated with tobacco use

Assignee: RESURGENT BIOSCIENCES INCPriority: Mar 6, 2016Filed: Jul 6, 2020Published: Oct 22, 2020
Est. expiryMar 6, 2036(~9.6 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61K 2236/39A24B 15/303A24D 3/14A24B 15/302A24B 3/12A61K 31/047A61K 2236/37A24D 1/002A61K 31/352A61K 36/185
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A substantially pure fraction of at least one cannabinoid is added to smokable or smokeless tobacco products to reduce the harm associated with tobacco use. The harm to be reduced includes irritation and carcinogenicity of tobacco. In a preferred embodiment a whole plant cannabis extract is mixed directly with the tobacco during the curing or manufacturing process. For cigarette applications the cannabinoids may be inserted into a cigarette filter, and/or paper. In other embodiments the cannabinoids are purified.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition of matter for consumption by a human comprising:
 tobacco; and   
       an isolated cannabinoid from cannabis to effectively reduce the harmful effects of tobacco use, wherein said cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol and mixtures thereof and wherein the combination of tobacco and isolated cannabinoid are in a form selected from the group consisting of cigarettes, cigars, chewing tobacco, and moist snuff. 
     
     
         2 . The composition of matter of  claim 1  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of about 1:20, tetrahydrocannabinol: cannabidiol. 
     
     
         3 . The composition of matter of  claim 1  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of between 1:20 to 20:1, tetrahydrocannabinol: cannabidiol. 
     
     
         4 . The composition of matter of  claim 1  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of about 1:1, tetrahydrocannabinol: cannabidiol. 
     
     
         5 . The composition of matter of  claim 1  wherein the isolated cannabinoid is a microencapsulated, highly purified cannabinoid isolate. 
     
     
         6 . The composition of matter of  claim 1  wherein the isolated cannabinoid is contained in an oil. 
     
     
         7 . The composition of matter of  claim 1  wherein the isolated cannabinoid is formulated as a dry component. 
     
     
         8 . The composition of matter of  claim 1  wherein the cannabidiol weight is between 0.1 and 5000 milligrams and the tobacco weight is between 400 to 1200 milligrams. 
     
     
         9 . The composition of matter of  claim 8  wherein the cannabidiol weight is between about 0.4 and 240 milligrams. 
     
     
         10 . A composition of matter for consumption by a human comprising:
 dried and cured tobacco particles; and   
       an isolated cannabinoid from cannabis to effectively reduce the harmful effects of tobacco use, wherein said cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol and mixtures thereof and wherein the combination of tobacco and isolated cannabinoid are in a form selected from the group consisting of cigarettes, cigars, chewing tobacco, and moist snuff. 
     
     
         11 . The composition of matter of  claim 10  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of about 1:20, tetrahydrocannabinol: cannabidiol. 
     
     
         12 . The composition of matter of  claim 10  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of between 1:20 to 20:1, tetrahydrocannabinol: cannabidiol. 
     
     
         13 . The composition of matter of  claim 10  wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of about 1:1, tetrahydrocannabinol: cannabidiol. 
     
     
         14 . The composition of matter of  claim 10  wherein the isolated cannabinoid is a microencapsulated, highly purified cannabinoid isolate. 
     
     
         15 . The composition of matter of  claim 10  wherein the isolated cannabinoid is contained in an oil. 
     
     
         16 . The composition of matter of  claim 10  wherein the isolated cannabinoid is formulated as a dry particle component. 
     
     
         17 . The composition of matter of  claim 10  wherein the cannabidiol weight is between 0.1 and 5000 milligrams and the tobacco weight is between 400 to 1200 milligrams. 
     
     
         18 . The composition of matter of  claim 17  wherein the cannabidiol weight is between about 0.4 and 240 milligrams. 
     
     
         19 . A composition of matter for consumption by a human comprising:
 dried and cured tobacco particles; and   a paper wrap encasing the tobacco particles and containing an isolated cannabinoid from cannabis to effectively reduce the harmful effects of tobacco use, wherein said cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol and mixtures thereof and wherein the combination of tobacco and isolated cannabinoid are in a form selected from the group consisting of cigarettes, cigars, and chewing tobacco.   
     
     
         20 . The composition of matter of  claim 19  wherein the paper wrap is tobacco paper or filter paper.

Join the waitlist — get patent alerts

Track US2020330537A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.